SERS tubing makes intravenous drug delivery safer


A sensor that identifies drugs compounds and monitors changes in their concentrations as they enter the body through an intravenous (IV) drip could prevent medication mistakes.

Over 60% of life-threatening errors during hospitalisation are attributed to the administration of incorrect dosages or combinations of IV drugs. Methods that detect and track drug administration in real time would add an extra layer of protection to IV drug delivery.

Recent research, led by Brian Cunningham at the University of Illinois in the US, has produced biomedical tubing that uses surface enhanced Raman spectroscopy (SERS) to monitor the contents and concentrations of drugs within a patient’s IV line.  

This is not the first time that SERS has been used to monitor IV drug delivery but this time it has been integrated with a plasmonic nanodome array (PNA) surface. The PNA surface enhances the Raman signals by a factor of around 5×108, to a level much higher than other commercially available SERS surfaces. Drugs can therefore be monitored at a range well below typical dosages.

The plasmonic nanodome array surface enhances the Raman signals

The tubing could detect 10 pharmaceutical compounds with reproducible signals for a period of up to five days. For four of the drugs, the signal magnitude was dependent upon the drug concentration and combinations of compounds could also be detected, giving a much more detailed picture of a patient’s medication.

Duncan Graham, a SERS expert at the University of Strathclyde in the UK, is impressed with ‘the excellent sensitivity and reproducibility’ shown by the device and says ‘being able to monitor drug levels in a simple and rapid manner will be advantageous for patient treatment.’ He adds that as common plastic tubing is used it is relatively compact and inexpensive to manufacture so could practically be adopted in a clinical setting as a single-use disposable device.

However, as Cunningham explains, ‘a current limitation is that combinations of drugs result in complex Raman spectra with some overlapping peaks, particularly for drugs that have similar molecular structures.’ Therefore, ‘future work will involve the characterisation of bigger sets of multi-drug combinations as well as miniaturising the detection instrument’.

References

This paper is free to access until 19 May 2014. Download it here:

H-Y Wu and B T Cunningham, Nanoscale, 2014, DOI: 10.1039/c4nr00027g 


Related Content

Pepping up antibiotics

29 September 2014 Premium contentFeature

news image

Industry and academia are turning to antimicrobial peptides to find new antibiotics, Andy Extance discovers

Chemistry World podcast - May 2013

2 May 2013 Podcast | Monthly

news image

Robert Lovitt tells us about algae biotechnology, Patrick Holland discusses nitrogen fixing chemistry and the team cover the ...

Most Read

UC Davis chemist sentenced to four years over explosion

19 November 2014 News and Analysis

news image

Postdoc sentenced over attempt to make explosive device and reckless disposal of hazardous waste

Grad student blamed for research misconduct at Utah

13 November 2014 News and Analysis

news image

Two papers have been retracted due to image falsification at the University of Utah

Most Commented

Beetle behind breath test for bank notes

17 November 2014 Research

news image

Photonic crystal inks inspired by longhorn beetle could help to fight counterfeiting

Bayer wins race to buy Merck & Co consumer care

9 May 2014 Business

news image

$14bn deal will make Aspirin inventor the number two over-the-counter healthcare company